Back to search

University of Birmingham

Investigating novel routes to high intratumoural immunity

Abstract

dc:description.abstract

Immune checkpoint blockade (ICB) has revolutionised treatment for high-mutation burden cancers that have deficient mismatch repair systems, and typically exhibit strong intratumoural immunity. However, extending this success to low-mutation burden settings that dominate many cancers remains a major challenge. For unknown reasons, low mutational cancer cohorts exhibit substantial heterogeneity in both the strength of intratumoural immunity, and in clinical prognosis. Colorectal cancer (CRC) represents a robust model to investigate such phenomena, since it comprises distinct subgroups that are ICB-responsive (microsatellite instability-high, MSI-H) and non-responsive (microsatellite stable, MSS) which exhibit high and low mutational burden, respectively. Utilising a TH1-centric signature, I demonstrate that MSS patients have a highly variable intratumoural immunity and that MHC Class II expression can stratify a high-immunity MSS subgroup (MSS-hi-CIRC). Subsequently, using multispectral immunofluorescence, I demonstrate that MSS-hi-CIRC patients have an immune infiltrate comparable to ICB-responsive CRC patients (MSI-H), despite substantially lower mutational loads and no specific genetic determinants. Finally, I demonstrate differences in the microenvironmental immunobiology of MSS-hi-CIRC and MSI-H patients that indicate distinct routes to establishing high intratumoural immunity and suggest MSS-hi-CIRC immunobiology results from microbiome-driven adjuntivisation of intratumoural immunity. Furthermore, by mining data from other low-mutation burden cancers, I demonstrate that MSS-hi-CIRC immunobiology defined here might occur across several cancer types. My results therefore indicate that MHC-II level stratifies patients with immunobiology like that of MSI-H patients, albeit arising from distinct mechanisms. The analyses and mechanistic model proposed have implications for both the understanding of differential clinical prognosis in MSS cancer patients, and for the development of new immunotherapies and microbiome-based therapies focussed on this grouping.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McMurray, Jack Luke
ORCID person:identifier.orcid

Subjects

dc:subject × 2

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
CRUK non-clinical studentship - 20258

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

McMurray, Jack Luke. Investigating novel routes to high intratumoural immunity. d_ph thesis, University of Birmingham, 2022.